Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-04

Clinical Trial Update: Immunogenicity and Safety of Subunit Plague Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the immunogenicity and safety of a subunit plague vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Subunit plague vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Plague | Phase 2 | Status: COMPLETED